Posts
-
As Patients Live Longer, New Criteria Needed for Prostate Cancer Trials
A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology.
-
New Anti-Blood Clotting Drug May Lower Risk of Recurrent Strokes
An experimental drug designed to block blood-clotting proteins may slightly lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.
-
Decorated Nanoparticles Prevent Allergic Reactions
Northwestern University scientists have developed the first selective nanoparticle therapy to prevent allergic reactions, which can range in severity from itchy hives and watery eyes to trouble breathing and even death.